Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Transactions
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
CC transcript
Appointed director
Inv. presentation
Acq. announced
ENDO HEALTH SOLUTIONS INC. (ENDP) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/28/2014 8-K Quarterly results
Docs: "ENDO REPORTS FOURTH QUARTER AND FULL YEAR 2013 FINANCIAL RESULTS"
08/06/2013 8-K Quarterly results
Docs: "ENDO REPORTS SECOND QUARTER FINANCIAL RESULTS"
05/07/2013 8-K Quarterly results
Docs: "ENDO REPORTS FIRST QUARTER FINANCIAL RESULTS"
02/28/2013 8-K Quarterly results
Docs: "ENDO REPORTS FOURTH QUARTER FINANCIAL RESULTS AND REAFFIRMS 2013 FINANCIAL GUIDANCE"
11/05/2012 8-K Quarterly results
Docs: "ENDO REPORTS THIRD QUARTER FINANCIAL RESULTS AND UPDATES 2012 FINANCIAL GUIDANCE"
08/07/2012 8-K Quarterly results
Docs: "ENDO REPORTS SECOND QUARTER FINANCIAL RESULTS AND UPDATES 2012 FINANCIAL GUIDANCE",
"Endo Health Solutions Announces Authorization of $450 Million Share Repurchase Program"
05/01/2012 8-K Quarterly results
Docs: "ENDO REPORTS FIRST QUARTER FINANCIAL RESULTS AND ANNOUNCES RETURN TO STEADY SUPPLY OF OPANA® ER AND VOLTAREN® GEL"
02/24/2012 8-K Quarterly results
Docs: "ENDO PHARMACEUTICALS REPORTS STRONG FOURTH QUARTER FINANCIAL RESULTS; PROVIDES 2012 FINANCIAL GUIDANCE",
"CERTAIN SUPPLEMENTAL INFORMATION NOT INCLUDED IN THE PRESS RELEASE"
10/27/2011 8-K Form 8-K - Current report
08/09/2011 8-K Form 8-K - Current report
04/28/2011 8-K Form 8-K - Current report
02/28/2011 8-K Quarterly results
Docs: "ENDO PHARMACEUTICALS RAISES 2011 FINANCIAL GUIDANCE AND REPORTS STRONG FOURTH QUARTER 2010 FINANCIAL RESULTS"
11/01/2010 8-K Form 8-K - Current report
07/30/2010 8-K Quarterly results
Docs: "ENDO PHARMACEUTICALS REPORTS STRONG SECOND QUARTER 2010 FINANCIAL RESULTS"
04/30/2010 8-K Form 8-K - Current report
02/22/2010 8-K Form 8-K - Current report
10/29/2009 8-K Form 8-K - Current report
07/30/2009 8-K Quarterly results
Docs: "ENDO PHARMACEUTICALS REPORTS STRONG SECOND QUARTER 2009 FINANCIAL RESULTS • 22 Percent Increase in Total Revenues versus Prior Year • Second Quarter Reported Adjusted diluted EPS of $0.73, Reported Diluted EPS of $0.26"
04/29/2009 8-K Form 8-K -- Current report
04/30/2008 8-K Quarterly results
Docs: "ENDO PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS"
02/22/2008 8-K Quarterly results
Docs: "ENDO PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL-YEAR FINANCIAL RESULTS FOR 2007"
11/01/2007 8-K Quarterly results
Docs: "ENDO PHARMACEUTICALS REPORTS THIRD QUARTER 2007 FINANCIAL RESULTS"
08/01/2007 8-K Quarterly results
Docs: "ENDO PHARMACEUTICALS REPORTS 2007 SECOND QUARTER FINANCIAL RESULTS"
04/27/2007 8-K Quarterly results
Docs: "ENDO PHARMACEUTICALS REPORTS FIRST QUARTER 2007 FINANCIAL RESULTS"
02/22/2007 8-K Quarterly results
Docs: "ENDO PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL-YEAR 2006 FINANCIAL RESULTS"
10/19/2006 8-K Quarterly results
Docs: "ENDO PHARMACEUTICALS REPORTS THIRD QUARTER 2006 FINANCIAL RESULTS"
07/20/2006 8-K Quarterly results
Docs: "ENDO PHARMACEUTICALS REPORTS 2006 SECOND QUARTER FINANCIAL RESULTS"
04/20/2006 8-K Quarterly results
Docs: "ENDO PHARMACEUTICALS REPORTS FIRST QUARTER 2006 FINANCIAL RESULTS"
02/15/2006 8-K Quarterly results
Docs: "PRESS RELEASE OF ENDO PHARMACEUTICALS HOLDINGS INC. DATED FERBRUARY 15, 2006"
10/20/2005 8-K Quarterly results
Docs: "ENDO PHARMACEUTICALS REPORTS THIRD QUARTER 2005 FINANCIAL RESULTS"
07/21/2005 8-K Quarterly results
Docs: "ENDO PHARMACEUTICALS REPORTS 2005 SECOND QUARTER FINANCIAL RESULTS"
04/21/2005 8-K Quarterly results
Docs: "ENDO PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS"
10/14/2004 8-K Quarterly results
Docs: "ENDO PHARMACEUTICALS REPORTS THIRD QUARTER 2004 FINANCIAL RESULTS"
07/15/2004 8-K Quarterly results
Docs: "ENDO LICENSES RIGHTS FROM VERNALIS TO MARKET ACUTE MIGRAINE TREATMENT FROVA™",
"ENDO PHARMACEUTICALS REPORTS SECOND QUARTER FINANCIAL RESULTS"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy